Liloglou T - Search Results

1

Rare deleterious germline variants and risk of lung cancer.

Liu Y, Xia J, McKay J, Tsavachidis S, Xiao X, Spitz MR, Cheng C, Byun J, Hong W, Li Y, Zhu D, Song Z, Rosenberg SM, Scheurer ME, Kheradmand F, Pikielny CW, Lusk CM, Schwartz AG, Wistuba II, Cho MH, Silverman EK, Bailey-Wilson J, Pinney SM, Anderson M, Kupert E, Gaba C, Mandal D, You M, de Andrade M, Yang P, Liloglou T, Davies MPA, Lissowska J, Swiatkowska B, Zaridze D, Mukeria A, Janout V, Holcatova I, Mates D, Stojsic J, Scelo G, Brennan P, Liu G, Field JK, Hung RJ, Christiani DC, Amos CI. Liu Y, et al. Among authors: liloglou t. NPJ Precis Oncol. 2021 Feb 16;5(1):12. doi: 10.1038/s41698-021-00146-7. NPJ Precis Oncol. 2021. PMID: 33594163 Free PMC article.

2

A T2517C polymorphism in the GSTM4 gene is associated with risk of developing lung cancer.

Liloglou T, Walters M, Maloney P, Youngson J, Field JK. Liloglou T, et al. Lung Cancer. 2002 Aug;37(2):143-6. doi: 10.1016/s0169-5002(02)00078-8. Lung Cancer. 2002. PMID: 12140136

3

p53 status correlates with the differential expression of the DNA mismatch repair protein MSH2 in non-small cell lung carcinoma.

Xinarianos G, Liloglou T, Prime W, Sourvinos G, Karachristos A, Gosney JR, Spandidos DA, Field JK. Xinarianos G, et al. Among authors: liloglou t. Int J Cancer. 2002 Sep 20;101(3):248-52. doi: 10.1002/ijc.10598. Int J Cancer. 2002. PMID: 12209975 Free article.

4

Fluorescent microsatellite analysis in bronchial lavage as a potential diagnostic tool for lung cancer.

Field JK, Liloglou T. Field JK, et al. Among authors: liloglou t. Methods Mol Med. 2003;75:251-62. doi: 10.1385/1-59259-324-0:251. Methods Mol Med. 2003. PMID: 12407745 No abstract available.

5

In-depth analysis of molecular alterations within normal and tumour tissue from an entire bronchial tree.

Sikkink SK, Liloglou T, Maloney P, Gosney JR, Field JK. Sikkink SK, et al. Among authors: liloglou t. Int J Oncol. 2003 Mar;22(3):589-95. Int J Oncol. 2003. PMID: 12579312

6

Defining high-risk individuals in a population-based molecular-epidemiological study of lung cancer.

Cassidy A, Myles JP, Liloglou T, Duffy SW, Field JK. Cassidy A, et al. Among authors: liloglou t. Int J Oncol. 2006 May;28(5):1295-301. Int J Oncol. 2006. PMID: 16596247

7

Frequent genetic and epigenetic abnormalities contribute to the deregulation of cytoglobin in non-small cell lung cancer.

Xinarianos G, McRonald FE, Risk JM, Bowers NL, Nikolaidis G, Field JK, Liloglou T. Xinarianos G, et al. Among authors: liloglou t. Hum Mol Genet. 2006 Jul 1;15(13):2038-44. doi: 10.1093/hmg/ddl128. Epub 2006 May 12. Hum Mol Genet. 2006. PMID: 16698880

8

Methylation enrichment pyrosequencing: combining the specificity of MSP with validation by pyrosequencing.

Shaw RJ, Akufo-Tetteh EK, Risk JM, Field JK, Liloglou T. Shaw RJ, et al. Among authors: liloglou t. Nucleic Acids Res. 2006 Jun 28;34(11):e78. doi: 10.1093/nar/gkl424. Nucleic Acids Res. 2006. PMID: 16807314 Free PMC article.

9

Lung cancer risk prediction: a tool for early detection.

Cassidy A, Duffy SW, Myles JP, Liloglou T, Field JK. Cassidy A, et al. Among authors: liloglou t. Int J Cancer. 2007 Jan 1;120(1):1-6. doi: 10.1002/ijc.22331. Int J Cancer. 2007. PMID: 17058200 Free article. Review.

10

CpG island methylation phenotype (CIMP) in oral cancer: associated with a marked inflammatory response and less aggressive tumour biology.

Shaw RJ, Hall GL, Lowe D, Bowers NL, Liloglou T, Field JK, Woolgar JA, Risk JM. Shaw RJ, et al. Among authors: liloglou t. Oral Oncol. 2007 Oct;43(9):878-86. doi: 10.1016/j.oraloncology.2006.10.006. Epub 2007 Jan 25. Oral Oncol. 2007. PMID: 17257884

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

164 results

Search Page